New Delhi: Bharat Biotech’s COVID-19 vaccine candidate COVAXIN has showed positive results in animal trials, announced on Saturday.
“Bharat Biotech proudly announces the animal study results of COVAXIN — these results demonstrate the protective efficacy in a live viral challenge model,” the firm said in a statement.
“The results showed protective efficacy, increasing SARS-CoV-2 specific IgG and neutralizing antibodies, reducing replication of the virus in the nasal cavity, throat, and lung tissues of the monkeys,” the statement added.
COVAXIN has been developed jointly by the Indian Council of Medical Research and Bharat Biotech. It is being tested at 12 institutes across India.
